How to Prevent Orthostatic Hypotension
Orthostatic hypotension—defined as a sustained drop in systolic blood pressure of at least 20 mm Hg or diastolic blood pressure of at least 10 mm Hg within three minutes of standing—is a common clinic
Orthostatic hypotension—defined as a sustained drop in systolic blood pressure of at least 20 mm Hg or diastolic blood pressure of at least 10 mm Hg within three minutes of standing—is a common clinical condition, particularly among older adults and individuals with autonomic dysfunction, Parkinson’s disease, or diabetes. Effective prevention hinges on nonpharmacologic strategies that support vascular tone, intravascular volume, and baroreflex responsiveness.
Gradual positional changes are foundational: patients should rise slowly from supine to seated, pause for 30–60 seconds, then stand deliberately while holding onto stable support. This allows time for sympathetic nervous system activation and peripheral vasoconstriction to counteract gravitational pooling of blood in the lower extremities.
Nonpharmacologic volume expansion is equally critical. Adequate hydration—typically 1.5–2 liters of fluid daily—and modest sodium intake (unless contraindicated by heart failure or hypertension) help maintain intravascular volume. Compression garments, especially waist-high medical-grade compression stockings (20–30 mm Hg), reduce venous capacitance and enhance venous return.
Lifestyle modifications include avoiding large carbohydrate-rich meals, which can induce postprandial hypotension via splanchnic vasodilation; limiting alcohol consumption, which impairs sympathetic compensation; and engaging in regular recumbent or resistance-based exercise to improve vascular conditioning and muscle pump efficiency.
Clinicians should also routinely review medications—including antihypertensives, diuretics, antidepressants, and dopaminergic agents—for potential contribution to orthostatic hypotension and consider dose adjustment or substitution when appropriate. In select cases, pharmacologic adjuncts such as fludrocortisone or midodrine may be warranted, but these remain secondary to comprehensive nonpharmacologic management.